Chapter 26: Caring for the Child With Cancer

Childhood cancer affects approximately 13,500 children annually in the United States, and while it remains a leading cause of disease-related mortality in this population, advances in therapeutic approaches have improved survival rates to exceed 80 percent. The chapter explores the fundamental disease mechanisms, including cellular anaplasia and the abnormal proliferation of cells derived from primitive embryonic tissues, along with the staging classification system that ranges from localized disease to advanced metastatic involvement. Recognition of early warning signs is critical for timely intervention, with pediatric-specific indicators including unexplained weight loss, persistent headaches, chronic bone pain, and recurrent infections. The most prevalent childhood malignancies are discussed in detail, including acute lymphocytic leukemia as the most common type, followed by brain tumors and solid organ cancers such as Wilms tumor, neuroblastoma, and retinoblastoma. The chapter emphasizes evidence-based nursing interventions prioritizing infection prevention through neutropenic precautions, nutritional support with high-calorie and high-protein intake, and developmentally appropriate pain management using validated assessment scales. Critical medical emergencies unique to the pediatric oncology population are presented, including septic shock in neutropenic patients, tumor lysis syndrome resulting from rapid malignant cell death, and hemorrhagic cystitis related to specific chemotherapeutic agents. Treatment modalities encompassing chemotherapy administration through central venous access devices, radiation therapy with age-specific considerations, and hematopoietic stem cell transplantation are examined alongside their associated toxicities and side effects. The chapter concludes by addressing the psychosocial dimensions of cancer care, including family coping mechanisms, sibling support, and the importance of monitoring cancer survivors for late effects such as secondary malignancies, cardiac complications, and reproductive dysfunction across the lifespan.